Viridian Therapeutics Inc... (VRDN)
NASDAQ: VRDN
· Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.50
-0.16%
After-hours: Aug 15, 2025, 07:26 PM EDT
Viridian Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -344.06M | -308.32M | -269.95M | -257.08M | -228.06M | -218.13M | -237.73M | -216.66M | -197.9M | -172.33M | -129.87M | -113.03M | -98.17M | -86.65M | -79.41M | -141.21M | -132.66M | -121.13M |
Depreciation & Amortization | -12.26M | -12.23M | -12.01M | -11.98M | 772K | 762K | 522K | 468K | 395K | 320K | 255K | 191K | 159K | 127K | 120K | 138K | 165K | 204K |
Stock-Based Compensation | 38.76M | 39.68M | 42.15M | 59.22M | 64.11M | 64.64M | 67.17M | 46.4M | 37.74M | 30.32M | 19.77M | 17.98M | 17.02M | 15.95M | 14.46M | 12.72M | 9.35M | 6.16M |
Other Working Capital | -9.02M | -9.66M | 519K | 3.28M | 8.3M | -3.21M | 2.62M | 995K | -158K | 696K | -88K | -3.24M | -2.66M | -1.1M | 69K | 116.64M | 145.61M | 169.92M |
Other Non-Cash Items | 12.2M | 9.56M | 19.92M | 23.2M | 5.53M | 14.65M | 3.63M | 2.63M | 1.56M | -3.41M | -206K | 8.36M | 9.05M | 7.81M | 7.49M | 71.92M | 70.96M | 72.43M |
Deferred Income Tax | n/a | n/a | n/a | -3.07M | -5.42M | -8.33M | -8.33M | -5.27M | -2.91M | n/a | n/a | 248K | 490K | 806K | 1.04M | 847K | 604K | 278K |
Change in Working Capital | -3.7M | -8.44M | 460K | 5.62M | 7.7M | -8.12M | -9.43M | -7.78M | -782K | 10.07M | 15.96M | 9.66M | 3.65M | -2.13M | 1.72M | 8.11M | 10.88M | 9.21M |
Operating Cash Flow | -309.06M | -279.75M | -232.32M | -196.99M | -168.26M | -167.42M | -184.17M | -180.21M | -161.9M | -134.77M | -93.84M | -76.33M | -67.54M | -64.08M | -54.58M | -47.48M | -40.7M | -32.86M |
Capital Expenditures | -535K | -597K | -511K | -445K | -556K | -783K | -898K | -1.08M | -772K | -733K | -797K | -650K | -740K | -502K | -338K | -201K | -69K | -15K |
Cash Acquisitions | n/a | n/a | n/a | 169.66M | 121.22M | 80.17M | 93.35M | 104.06M | 152.51M | 193.55M | 180.37M | 2K | 4K | 79K | 79K | 2.08M | 2.08M | 2M |
Purchase of Investments | -537.2M | -540.7M | -695.07M | -785.78M | -607.41M | -556.21M | -407.88M | -353.46M | -303.41M | -295.35M | -223.26M | -108.08M | -126.24M | -136.97M | -188.43M | -167.35M | -149.19M | -138.46M |
Sales Maturities Of Investments | 565.93M | 555.75M | 466.93M | 450.78M | 405.23M | 332.99M | 314.53M | 249.39M | 193.65M | 158.8M | 108.94M | 93.99M | 75.84M | 61.09M | 114.4M | 89.64M | 65.04M | 65.54M |
Other Investing Acitivies | n/a | n/a | -143.04M | -312.71M | -264.26M | -223.22M | -93.35M | -104.06M | -109.76M | -136.55M | -114.33M | 66.05M | 23.3M | 9.12M | 10.97M | 40.29M | 40.29M | 40.21M |
Investing Cash Flow | 28.2M | 14.46M | -228.65M | -335.45M | -202.74M | -224M | -94.25M | -105.14M | -110.53M | -137.28M | -115.13M | -14.73M | -51.13M | -76.3M | -74.29M | -46.51M | -52.81M | -41.61M |
Debt Repayment | n/a | n/a | n/a | n/a | 15M | 15M | 15M | 15.45M | 446K | 446K | 446K | n/a | n/a | n/a | n/a | -8.96M | -8.96M | -7.57M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 320K | 320K | 320K | 320K | 71K | 71K | 71K | 71K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 16.31M | 15.65M | 2.2M | -121K | -10.94M | -7.98M | 9.41M | 12.21M | 35.9M | 37.39M | 29.92M | 28.61M | 16.55M | 11.77M | 11.03M | 97.91M | 85.75M | 85.84M |
Financial Cash Flow | 290.52M | 289.87M | 457.74M | 621.15M | 391.59M | 394.55M | 225.67M | 52.74M | 328.22M | 329.71M | 322.24M | 296.4M | 122.26M | 124.75M | 125.28M | 202.79M | 90.64M | 84.86M |
Net Cash Flow | 9.66M | 24.57M | -3.23M | 88.72M | 20.59M | 3.13M | -52.75M | -232.61M | 55.79M | 57.66M | 113.28M | 205.34M | 3.59M | -15.63M | -3.6M | 108.8M | -2.88M | 10.39M |
Free Cash Flow | -309.6M | -280.35M | -232.83M | -197.43M | -168.82M | -168.2M | -185.07M | -181.29M | -162.67M | -135.5M | -94.64M | -76.98M | -68.28M | -64.59M | -54.92M | -47.68M | -40.77M | -32.87M |